Placenta-Based injection trial seeks to tame liver disease
NCT ID NCT06493799
Summary
This study is testing if giving a medication called LAENNEC through an IV drip works as well or better than the usual shot under the skin for people with chronic liver disease. About 226 adults with alcoholic or non-alcoholic fatty liver disease will receive one of the two methods twice a week for 6 weeks. The main goal is to see which method is better at lowering a key liver enzyme (ALT) and improving fatigue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
GC wellbeing
RECRUITINGYongin-si, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.